Journal articleOphthalmol Sci · August 2026
PURPOSE: To evaluate the proportion of eyes with fibrosis in the Archway neovascular age-related macular degeneration trial, which compared efficacy and safety between monthly injections of ranibizumab with treatment via the Port Delivery Platform with ran ...
Full textLink to itemCite
Journal articleOphthalmol Retina · July 20, 2026
PURPOSE: To assess anatomic and visual function data from 3 randomized, sham-controlled clinical trials of revakinagene taroretcel-lwey in participants with macular telangiectasia type 2 (MacTel). DESIGN: This study pooled data from 1 Phase 2 (NTMT-02) cli ...
Full textLink to itemCite
Journal articleOphthalmol Retina · June 2026
PURPOSE: To highlight the role of en face OCT in the measurement of choroidal hypertransmission defects (hyperTDs) in complete retinal pigment epithelial and outer retinal atrophy (cRORA), and to refine the definition of retinal pigment epithelium (RPE)-re ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · May 19, 2026
PURPOSE: To report disease progression of ring melanoma. METHODS: A comprehensive chart review was conducted. RESULTS: A 75-year-old male presented with persistent floaters and reduced visual acuity in the right eye. On diagnostic and therapeutic vitrectom ...
Full textLink to itemCite
Journal articleRetina · May 1, 2026
PURPOSE: To evaluate the safety and efficacy of multiwavelength photobiomodulation (PBM) in nonexudative (dry) age-related macular degeneration (AMD). METHODS: LIGHTSITE III used a double-masked, randomized, sham-controlled, parallel-group, prospective stu ...
Full textLink to itemCite
Journal articleOphthalmology · April 2026
PURPOSE: Avacincaptad pegol (ACP) is a pegylated RNA aptamer that inhibits complement C5. The efficacy and safety of ACP 2 mg was investigated in GATHER2, with positive year 1 results published. Herein, 2-year results are reported. DESIGN: Phase 3, randomi ...
Full textLink to itemCite
Journal articleOphthalmol Sci · April 2026
PURPOSE: To determine the functional characteristics of color fundus photograph (CFP)- and fundus autofluorescence (FAF)-defined geographic atrophy (GA) lesions by evaluating the prevalence of repeatable deep visual sensitivity defects. DESIGN: Reader stud ...
Full textLink to itemCite
Journal articleOphthalmol Sci · February 2026
PURPOSE: To evaluate conventional imaging modalities for detecting fibrosis in neovascular age-related macular degeneration (nAMD) and to develop a standardized diagnostic workflow. DESIGN: Systematic discussion and grading exercise assessing multiple imag ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · December 31, 2025
PURPOSE: To present a case of bilateral severe Harada-like reaction with bacillary layer detachments secondary to pembrolizumab therapy for metastatic signet ring cell carcinoma. METHODS: Case report. RESULTS: A 33-year-old black male with a medical histor ...
Full textLink to itemCite
Journal articleDiagnostics (Basel) · December 5, 2025
Background/Objectives: Anterior segment optical coherence tomography (AS-OCT) is a non-invasive imaging modality used to evaluate anterior segment features. This report aims to inform clinicians of best practices to obtain high-resolution AS-OCT images of ...
Full textLink to itemCite
Journal articleRetina · November 1, 2025
BACKGROUND/PURPOSE: To assess the effects of faricimab versus aflibercept on epiretinal membrane (ERM) formation in eyes with diabetic macular edema. METHODS: Post hoc analysis of phase 3 YOSEMITE/RHINE trial data in eyes with diabetic macular edema receiv ...
Full textLink to itemCite
Journal articleOphthalmol Retina · August 2025
PURPOSE: To compare the development of macular atrophy (MA) in eyes treated with the Port Delivery System with ranibizumab (PDS) with those treated with monthly intravitreal ranibizumab injections in the Archway trial. DESIGN: Preplanned exploratory analys ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · August 2025
PURPOSE: To compare the corticosteroid sparing efficacy of frequently used antimetabolites to tumor necrosis factor (TNF) inhibitors in the management of noninfectious ocular inflammation. METHODS: Retrospective analysis of patients with noninfectious uvei ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · August 2025
PURPOSE: To describe the natural history of optical coherence tomography (OCT) and mesopic microperimetry (MP) parameters in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) study. DESIGN: Multicenter, international, prospective, long ...
Full textLink to itemCite
Journal articleNEJM Evid · August 2025
BACKGROUND: Revakinagene taroretcel (NT-501) is an encapsulated cell therapy producing ciliary neurotrophic factor that slowed retinal degeneration in patients with macular telangiectasia type 2 (MacTel) in phase 2 trials. METHODS: In NTMT-03-A and NTMT-03 ...
Full textLink to itemCite
Journal articleExp Eye Res · June 2025
A greater understanding of the pathophysiology of AMD has yielded potential therapeutic strategies for slowing vision loss. Structural imaging biomarkers and novel functional outcomes, both under intensive study as surrogate endpoints in AMD clinical trial ...
Full textLink to itemCite
Journal articleAm J Med Open · June 2025
BACKGROUND: Returning results to research participants is increasingly recognized as an ethical mandate, yet little is known about best practices to optimally communicate urgent or emergent results. METHODS: We describe the development of and experience wi ...
Full textLink to itemCite
Journal articleOphthalmology · February 2025
PURPOSE: To report the safety and efficacy of brolucizumab (Beovu) 6 mg versus aflibercept (Eylea) 2 mg administered every 4 weeks in participants with neovascular age-related macular degeneration (nAMD) and persistent retinal fluid after the week 52 up to ...
Full textLink to itemCite
Journal articleOphthalmol Glaucoma · 2025
PURPOSE: To evaluate the incidence of failure of trabeculectomy versus tube shunt (TS) glaucoma surgery in eyes of patients with uveitis. DESIGN: Multicenter retrospective cohort study. PARTICIPANTS: Among 356 eyes of 288 patients with noninfectious inflam ...
Full textLink to itemCite
Journal articleOphthalmol Sci · 2025
PURPOSE: To identify combination(s) of OCT changes that define atrophic age-related macular degeneration (AMD) lesions associated with repeatable deep visual sensitivity defects. DESIGN: Reader study. PARTICIPANTS: One hundred seventy-one OCT scans from 60 ...
Full textLink to itemCite
Journal articleExp Eye Res · November 2024
Oxidative stress-mediated retinal pigment epithelial (RPE) cell damage is associated with age-related macular degeneration (AMD). ST266 is the biological secretome produced by a novel population of amnion-derived multipotent progenitor cells. Herein, we in ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · October 2024
PURPOSE: To describe a case of bilateral panuveitis in an 11-year-old girl with autoimmune lymphoproliferative syndrome (ALPS) due to CTLA4 haploinsufficiency. CASE DESCRIPTION: A 5-year-old girl developed cervical adenopathy, and autoimmune hemolytic anem ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 2024
PURPOSE: To compare fundus autofluorescence (FAF) and spectral domain optical coherence tomography (OCT) measurements of geographic atrophy (GA) area and to analyze lesion area changes measured by spectral domain OCT in GATHER1. DESIGN: An assessment relia ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · October 1, 2024
PURPOSE: To evaluate functional and structural assessments as endpoints for clinical trials for USH2A-related retinal degeneration. METHODS: People with biallelic disease-causing variants in USH2A, visual acuity ≥ 20/80, and visual field ≥ 10° diameter wer ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · July 1, 2024
PURPOSE: To report primary vitreoretinal lymphoma after surgical 0.59 mg fluocinolone acetonide implant (FAi) exchange in a patient treated with adalimumab for idiopathic bilateral panuveitis. METHODS: Retrospective case review. RESULTS: A 37-year-old woma ...
Full textLink to itemCite
Journal articleOphthalmology · June 2024
PURPOSE: To evaluate the 2-year efficacy, durability, and safety of dual angiopoietin-2 and vascular endothelial growth factor (VEGF) A pathway inhibition with intravitreal faricimab according to a personalized treat-and-extend (T&E)-based regimen with up ...
Full textLink to itemCite
Journal articleLancet · April 20, 2024
BACKGROUND: Frequent anti-vascular endothelial growth factor A (VEGF-A) injections reduce the risk of rapid and severe vision loss in patients with neovascular age-related macular degeneration (nAMD); however, due to undertreatment, many patients lose visi ...
Full textLink to itemCite
Journal articleOphthalmol Retina · April 2024
OBJECTIVE: To assess the feasibility of daily Home OCT imaging among patients with neovascular age-related macular degeneration (nAMD). DESIGN: Prospective observational study. PARTICIPANTS: Participants with ≥ 1 eye with previously untreated nAMD and visu ...
Full textLink to itemCite
Journal articleRetina · March 1, 2024
PURPOSE: The LIGHTSITE III study evaluated multiwavelength photobiomodulation (PBM) therapy in nonexudative (dry) age-related macular degeneration (AMD) using the LumiThera Valeda Light Delivery System. METHODS: LIGHTSITE III is a randomized, controlled tr ...
Full textLink to itemCite
Journal articleOphthalmol Sci · 2024
OBJECTIVE: To validate GATHER-1 inclusion criteria and the study's primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility. DESIGN: Post hoc analysis of phase II/III clinic ...
Full textLink to itemCite
Journal articleJ Vitreoretin Dis · 2024
Purpose: To analyze post-marketing cases of retinal vasculitis after intravitreal pegcetacoplan. Methods: The American Society of Retina Specialists (ASRS) Research and Safety in Therapeutics (ReST) Committee as well as an expert panel performed a retrospe ...
Full textLink to itemCite
Journal articleOphthalmology science · December 2023
PurposeTo determine the interreader agreement for reticular pseudodrusen (RPD) assessment on combined infrared reflectance (IR) and OCT imaging in the early stages of age-related macular degeneration across a range of different criteria to define ...
Full textOpen AccessCite
Journal articleLancet · October 21, 2023
BACKGROUND: Geographic atrophy is an advanced form of dry age-related macular degeneration that can lead to irreversible vision loss and high burden of disease. We aimed to assess efficacy and safety of avacincaptad pegol 2 mg in reducing geographic atroph ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · September 1, 2023
PURPOSE: The purpose of this study was to report a case of Pseudomonas aeruginosa endophthalmitis after surgical 0.59 mg fluocinolone acetonide implant in a patient with a long-standing Crawford tube. METHODS: This was a retrospective case review. RESULTS: ...
Full textLink to itemCite
Journal articleOphthalmol Ther · August 2023
INTRODUCTION: The HAWK and HARRIER studies evaluated the efficacy and safety of brolucizumab versus aflibercept in treatment-naïve eyes with neovascular age-related macular degeneration. Based on the study design, brolucizumab-treated eyes adjusted to a q8 ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · July 2023
BACKGROUND/AIMS: To describe the clinical impact of external limiting membrane (ELM) disruption, ellipsoid zone (EZ) disruption and subretinal fluid (SRF) seen on optical coherence tomography (OCT) in eyes with vitreomacular traction (VMT) without macular ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · July 2023
BACKGROUND: Thiazolidinediones, commonly used antidiabetic medications, have been associated with an increased risk of development of diabetic macular oedema and increased vascular endothelial cell permeability. Macular neovascularisation in age-related ma ...
Full textLink to itemCite
Journal articleRetina · June 1, 2023
PURPOSE: To report the outcomes of the 0.18 mg fluocinolone acetonide insert (FAi) in the treatment of chronic (>6 months) postoperative cystoid macular edema after cataract surgery. METHODS: This was a retrospective consecutive case series of eyes with ch ...
Full textLink to itemCite
Journal articleBMJ Oncol · 2023
OBJECTIVE: Evaluate the association between cancer incidence and immunosuppressive treatment in patients with ocular inflammatory disease (OID). METHODS AND ANALYSIS: We performed a retrospective cohort study of patients from 10 US OID subspecialty practic ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · December 2022
PURPOSE: To investigate baseline mesopic microperimetry (MP) and spectral domain optical coherence tomography (OCT) in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) study. DESIGN: Natural history study METHODS: Setting: 16 clinical ...
Full textLink to itemCite
Journal articleOphthalmol Retina · November 2022
OBJECTIVE: The purpose of the study was to perform a post hoc analysis to explore the effect of baseline anatomic characteristics identified on OCT on best-corrected visual acuity (BCVA) responses to risuteganib from the completed phase II study in subject ...
Full textLink to itemCite
Journal articleClin Exp Ophthalmol · September 27, 2022
The uveitides are a collection of over 30 diseases characterised by intraocular inflammation. Previous work demonstrated that the agreement among uveitis experts on diagnosis was modest at best with some pairs of experts having chance alone agreement on se ...
Full textLink to itemCite
Journal articleOphthalmol Retina · September 2022
PURPOSE: To determine whether the rates of macular atrophy (MA) differ between eyes with neovascular age-related macular degeneration (nAMD) treated continuously with the Port Delivery System with ranibizumab (PDS) and those treated with ranibizumab given ...
Full textLink to itemCite
Journal articleOphthalmology · September 2022
PURPOSE: To assess the 52-week efficacy and safety of brolucizumab 6 mg administered every 4 weeks compared with aflibercept 2 mg dosed every 4 weeks in eyes with neovascular age-related macular degeneration (nAMD) and persistent retinal fluid. DESIGN: Mul ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · July 2022
PURPOSE: To compare the efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy (PCV) over 96 weeks in the HAWK study. DESIGN: HAWK was a global, 2-year, randomised, double-masked, multicentre phase III trial i ...
Full textLink to itemCite
Journal articleRetina · July 1, 2022
PURPOSE: To assess the generalizability of a deep learning-based algorithm to segment the ellipsoid zone (EZ). METHODS: The dataset consisted of 127 spectral-domain optical coherence tomography volumes from eyes of participants with USH2A-related retinal d ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · March 2022
AIM: To develop a fully automatic algorithm to segment retinal cavitations on optical coherence tomography (OCT) images of macular telangiectasia type 2 (MacTel2). METHODS: The dataset consisted of 99 eyes from 67 participants enrolled in an international, ...
Full textLink to itemCite
Journal articleOphthalmol Retina · January 2022
PURPOSE: To determine the interreader agreement for incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA) and complete RPE and outer retinal atrophy (cRORA) and their related features in age-related macular degeneration (AMD). DESIG ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · December 1, 2021
PURPOSE: The purpose of this study was to evaluate the safety and preliminary efficacy of a single intravitreal injection of 3 dose levels of THR-149 in adults with center-involved diabetic macular edema (DME). METHODS: A phase 1, open-label, multicenter 3 ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · December 1, 2021
PURPOSE: Develop equations to convert Cirrus central subfield thickness (CST) to Spectralis CST equivalents and vice versa in eyes with diabetic macular edema (DME). METHODS: The DRCR Retina Network Protocol O data were split randomly to train (70% sample) ...
Full textLink to itemCite
Journal articleOphthalmology · November 2021
PURPOSE: To evaluate pneumatic vitreolysis (PVL) in eyes with vitreomacular traction (VMT) with and without full-thickness macular hole (FTMH). DESIGN: Two multicenter (28 sites) studies: a randomized clinical trial comparing PVL with observation (sham inj ...
Full textLink to itemCite
Journal articleOphthalmol Retina · October 2021
OBJECTIVE: To describe predominantly persistent subretinal fluid (SRF) in eyes receiving ranibizumab or bevacizumab for neovascular age-related macular degeneration and to compare visual acuity (VA) to eyes with nonpersistent SRF. DESIGN: Cohort within ran ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · September 1, 2021
PURPOSE: To demonstrate a rapid improvement of recalcitrant cystoid macular edema (CME) and perivascular leakage, in a patient with non-paraneoplastic autoimmune retinopathy and autoimmune optic neuropathy after treatment with sarilumab, a human anti-inter ...
Full textLink to itemCite
Journal articleOphthalmol Retina · September 2021
PURPOSE: To provide an image-based description of retinal features associated with risk for development of geographic atrophy (GA) in eyes with age-related macular degeneration (AMD), as visualized with multimodal imaging anchored by structural OCT. DESIGN ...
Full textLink to itemCite
Journal articleOphthalmol Sci · September 2021
PURPOSE: To evaluate the safety and preliminary efficacy of THR-687 in patients with center-involved diabetic macular edema (DME). DESIGN: Phase 1, open-label, multicenter, 3Â + 3 dose-escalation study with 3-month follow-up. PARTICIPANTS: Patients 18 years ...
Full textLink to itemCite
Journal articleRetina · August 1, 2021
PURPOSE: To determine the relationship of drusen size as determined by spectral-domain optical coherence tomography (SD-OCT) with that measured on registered color fundus photography (CFP) images and to derive an OCT-based classification system that was co ...
Full textLink to itemCite
Journal articleOphthalmology · July 2021
PURPOSE: An independent Safety Review Committee (SRC), supported by Novartis Pharma AG, analyzed investigator-reported cases of intraocular inflammation (IOI), endophthalmitis, and retinal arterial occlusion in the phase 3 HAWK and HARRIER trials of broluc ...
Full textLink to itemCite
Journal articleOphthalmology · June 2021
PURPOSE: To evaluate long-term efficacy and safety of extended treatment with adalimumab in patients with noninfectious intermediate, posterior, or panuveitis. DESIGN: Open-label, multicenter, phase 3 extension study (VISUAL III). PARTICIPANTS: Adults who ...
Full textLink to itemCite
Journal articleOphthalmology · May 2021
PURPOSE: To evaluate the long-term outcomes of uveitic macular edema (ME). DESIGN: Longitudinal follow-up of a cohort of participants in a randomized clinical trial. PARTICIPANTS: A total of 248 eyes of 177 participants with uveitic ME enrolled in the Mult ...
Full textLink to itemCite
Journal articleOphthalmology · April 2021
PURPOSE: The complement pathway may play a key role in the pathogenesis of age-related macular degeneration (AMD). The safety and efficacy of avacincaptad pegol (Zimura, IVERIC bio Inc, New York, NY), a C5 inhibitor, were assessed in participants with geog ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · March 2021
PURPOSE: To identify precursors of macular atrophy (MA) and of fibrotic scar (FS) in eyes treated with anti-vascular endothelial growth factor through pixel-mapping analysis of baseline optical coherence tomography (OCT). METHODS: Design: Cross-sectional a ...
Full textLink to itemCite
Journal articleExp Eye Res · March 2021
PURPOSE: Complement activation is associated with choroidal neovascularization (CNV) in age-related macular degeneration (AMD). Fibroblast growth factor 2 (FGF2) and membrane attack complex (MAC) are present in eyes of patients with CNV. Herein, we investi ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · January 1, 2021
In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, ...
Full textLink to itemCite
Journal articleEye (Lond) · December 2020
BACKGROUND/OBJECTIVES: To compare the detailed optical coherence tomography (OCT)-based morphological parameters of pigment epithelial detachment (PED) in eyes presenting with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vas ...
Full textLink to itemCite
Journal articleJ Ophthalmic Inflamm Infect · November 30, 2020
BACKGROUND: The current article is a short review of an Alimera Sciences-sponsored symposium held during The 15th International Ocular Inflammation Society Congress in Taiwan on the 14th November 2019 entitled, 'Preventing relapse of non-infectious uveitis ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · November 2020
PURPOSE: To report baseline visual fields in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) study. DESIGN: Cross-sectional study within a natural history study. METHODS: Setting: multicenter, international. STUDY POPULATION: Usher s ...
Full textOpen AccessLink to itemCite
Journal articleOphthalmology · October 2020
PURPOSE: To examine the 36-month efficacy and safety of a 0.2 μg/day fluocinolone acetonide insert (FAi) to treat noninfectious uveitis of the posterior segment (NIU-PS). DESIGN: Phase 3, prospective, double-masked, multicenter study (clinicaltrials.gov, N ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 3, 2020
PURPOSE: Cigarette smoking has been implicated in the pathogenesis of AMD. Integrin dysfunctions have been associated with AMD. Herein, we investigate the effect of risuteganib (RSG), an integrin regulator, on RPE cell injury induced by hydroquinone (HQ), ...
Full textLink to itemCite
Journal articleRetina · May 2020
PURPOSE: To evaluate the association of subretinal hyperreflective material (SHRM) morphological features with visual acuity in eyes with neovascular age-related macular degeneration. METHODS: Retrospective analysis of treatment-naïve patients with neovasc ...
Full textLink to itemCite
Journal articleOphthalmology · May 2020
TOPIC: To summarize the rates of atrophy, risk factors, and atrophy-associated visual outcomes in patients with neovascular age-related macular degeneration (nAMD) who received anti-vascular endothelial growth factor (VEGF) treatment for macular neovascula ...
Full textLink to itemCite
Journal articleGraefes Arch Clin Exp Ophthalmol · May 2020
PURPOSE: To determine the time to disease recurrence with long-acting injectable fluocinolone acetonide implant (FAi) for noninfectious intermediate, posterior, and panuveitis. METHODS: This was a retrospective study of patients with at least 12Â months of ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · April 9, 2020
PURPOSE: Oxidative stress in retinal pigment epithelial (RPE) cells is associated with age-related macular degeneration (AMD). Resveratrol exerts a range of protective biologic effects, but its mechanism(s) are not well understood. The aim of this study wa ...
Full textOpen AccessLink to itemCite
Journal articleOphthalmology · April 2020
OBJECTIVE: To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for 2 years and to describe the impact of switching to as-needed treatment after 1 year of monthly treatment. DESIGN: Multicenter, randomized clinical tria ...
Full textLink to itemCite
Journal articleOphthalmology · March 2020
PURPOSE: To describe the defining features of incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA), a consensus term referring to the OCT-based anatomic changes often identified before the development of complete RPE and outer reti ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · March 1, 2020
IMPORTANCE: Identifying the characteristics of eyes with neovascular age-related macular degeneration (nAMD) that maintain good vision without anti-vascular endothelial growth factor treatment for at least 3 years after management, as occurred in the Compa ...
Full textLink to itemCite
Journal articleRetin Cases Brief Rep · 2020
PURPOSE: To demonstrate improvement and stabilization of retinal findings, including recalcitrant cystoid macular edema, in a patient with nonparaneoplastic autoimmune retinopathy after treatment with tocilizumab, a humanized monoclonal antibody against so ...
Full textLink to itemCite
Journal articleOphthalmology · January 2020
PURPOSE: Two similarly designed phase 3 trials (HAWK and HARRIER) compared brolucizumab, a single-chain antibody fragment that inhibits vascular endothelial growth factor-A, with aflibercept to treat neovascular age-related macular degeneration (nAMD). DES ...
Full textLink to itemCite
Journal articleNPJ Digit Med · 2020
The Project Baseline Health Study (PBHS) was launched to map human health through a comprehensive understanding of both the health of an individual and how it relates to the broader population. The study will contribute to the creation of a biomedical info ...
Full textOpen AccessLink to itemCite
Journal articleOphthalmol Retina · December 2019
PURPOSE: To describe the rate of development and progression of fibrosis and macular atrophy (MA) and their relationship with 1-year visual outcomes in Asian participants with neovascular age-related macular degeneration (nAMD). DESIGN: Review of images co ...
Full textLink to itemCite
Journal articleOphthalmology · December 2019
PURPOSE: To assess macular vasculature in healthy infants and children using OCT angiography (OCTA). DESIGN: Prospective cross-sectional study. PARTICIPANTS: One hundred thirty-five normal maculae of 89 healthy infants and children (mean age, 8.5±5.3 years ...
Full textOpen AccessLink to itemCite
Journal articleRetina · May 2019
PURPOSE: In this study, we hypothesized that thickening along the major arcade vessels is a noninvasive marker of inflammation in eyes with birdshot retinochoroiditis (BRC). METHODS: In this single-center retrospective study, patients with BRC were identif ...
Full textLink to itemCite
Journal articleOphthalmology · May 2019
PURPOSE: To describe changes in visual acuity (VA) and macular morphologic features at 5 years in eyes with nonfibrotic scar (NFS) identified at 1 year in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Prospective coho ...
Full textLink to itemCite
Journal articleOphthalmic Surg Lasers Imaging Retina · May 1, 2019
The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive loc ...
Full textLink to itemCite
Journal articleOphthalmology · April 2019
PURPOSE: To test the effects of an encapsulated cell-based delivery of a neuroprotective agent, ciliary neurotrophic factor (CNTF), on progression of macular telangiectasia type 2, a neurodegenerative disease with no proven effective therapy. DESIGN: Rando ...
Full textLink to itemCite
Journal articleOphthalmology · April 2019
PURPOSE: To assess the safety and efficacy of an intravitreal fluocinolone acetonide (FA) insert to manage inflammation associated with chronic noninfectious posterior uveitis. DESIGN: Multicenter, randomized, prospective, doubled-masked, sham-controlled, ...
Full textLink to itemCite
Journal articleOphthalmol Retina · April 2019
PURPOSE: Macular atrophy and scar increase in prevalence during treatment for neovascular age-related macular degeneration and are associated with poor visual acuity. We sought to identify the distribution of spectral-domain OCT (SD-OCT)-determined feature ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · April 2019
The Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies were designed to measure the progression of Stargardt disease through the use of fundus autofluorescence imaging, optical coherence tomography, and microperimetry. The overarching ...
Full textLink to itemCite
Journal articleOphthalmology · February 2019
PURPOSE: To investigate the natural history and genetic associations of drusenoid pigment epithelial detachment (DPED) associated with age-related macular degeneration (AMD). DESIGN: Retrospective analysis of a prospective cohort study. PARTICIPANTS: Of th ...
Full textLink to itemCite
Journal articleOphthalmology · February 2019
PURPOSE: To evaluate the comparative effectiveness of 3 regional corticosteroid injections for uveitic macular edema (ME): periocular triamcinolone acetonide (PTA), intravitreal triamcinolone acetonide (ITA), and the intravitreal dexamethasone implant (IDI ...
Full textLink to itemCite
Journal articleRetina · January 2019
PURPOSE: Compare changes in retinal nerve fiber layer (RNFL) thickness between eyes assigned to intravitreous ranibizumab or panretinal photocoagulation and assess correlations between changes in RNFL and visual field sensitivity and central subfield thick ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · 2019
PURPOSE: Report global adalimumab safety and efficacy outcomes in patients with non-infectious uveitis. METHODS: Adults with non-infectious intermediate, posterior, or panuveitis were randomized 1:1 to receive placebo or adalimumab in the VISUAL I (active ...
Full textLink to itemCite
Journal articleOphthalmol Retina · January 2019
PURPOSE: To describe the clinical impact of subfoveal lucency (SFL) seen on OCT before and after treatment of vitreomacular traction (VMT) or symptomatic vitreomacular adhesion (VMA) without macular hole (MH) in the prospective phase 3 trials of ocriplasmi ...
Full textLink to itemCite
Journal articleOphthalmology · December 2018
PURPOSE: To analyze the prevalence, incidence, and clinical characteristics of eyes with geographic atrophy (GA) in age-related macular degeneration (AMD), including clinical and genetic factors affecting enlargement. DESIGN: Prospective cohort study withi ...
Full textLink to itemCite
Journal articleIndian J Ophthalmol · December 2018
Optical coherence tomography (OCT) angiography is a promising technique that provides depth resolved images of blood flow in the retina and choroid with levels of detail far exceeding that obtained with older forms of imaging and offers several advantages ...
Full textLink to itemCite
Journal articleGraefes Arch Clin Exp Ophthalmol · October 2018
PURPOSE: To determine the relationship between cystoid macular edema (CME) and disease severity and progression in non-paraneoplastic autoimmune retinopathy (npAIR). METHODS: A retrospective study was conducted on patients seen between 2008 and 2016 with n ...
Full textLink to itemCite
Journal articleOphthalmology · July 2018
PURPOSE: To evaluate safety and efficacy of adalimumab in patients with noninfectious intermediate, posterior, or panuveitis. DESIGN: Phase 3, open-label, multicenter clinical trial extension (VISUAL III). PARTICIPANTS: Adults meeting treatment failure (TF ...
Full textLink to itemCite
Journal articleOphthalmology · July 2018
PURPOSE: To describe risk factors for scar formation and changes to fibrotic scar through 5 years in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). DESIGN: Multicenter, prospective cohort study. PARTICIPANTS: A total of 1061 s ...
Full textLink to itemCite
Journal articleOphthalmology · July 2018
PURPOSE: To assess systemic vascular endothelial growth factor (VEGF)-A levels after treatment with intravitreous aflibercept, bevacizumab, or ranibizumab. DESIGN: Comparative-effectiveness trial with participants randomly assigned to 2 mg aflibercept, 1.2 ...
Full textLink to itemCite
Journal articleOphthalmol Retina · June 2018
PURPOSE: To determine baseline predictors of visual acuity (VA) outcomes at 5 years after initiating treatment with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). DESIGN: Secondary analysis of data from a cohort study. P ...
Full textLink to itemCite
Journal articleBiomed Opt Express · June 1, 2018
Photoreceptor ellipsoid zone (EZ) defects visible on optical coherence tomography (OCT) are important imaging biomarkers for the onset and progression of macular diseases. As such, accurate quantification of EZ defects is paramount to monitor disease progr ...
Full textLink to itemCite
Journal articleOphthalmol Retina · May 2018
PURPOSE: To develop methods to make precise comparisons of specific retinal features between and within spectral-domain (SD) OCT images, color fundus photography (CFP) images, and fluorescein angiography (FA) images in eyes treated with anti-vascular endot ...
Full textLink to itemCite
Journal articleOphthalmology · April 2018
PURPOSE: To develop consensus terminology and criteria for defining atrophy based on OCT findings in the setting of age-related macular degeneration (AMD). DESIGN: Consensus meeting. PARTICIPANTS: Panel of retina specialists, image reading center experts, ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · February 2018
PURPOSE: To evaluate the interobserver agreement among uveitis experts on the diagnosis of the specific uveitic disease. DESIGN: Interobserver agreement analysis. METHODS: Five committees, each comprised of 9 individuals and working in parallel, reviewed c ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · January 1, 2018
IMPORTANCE: Some eyes have persistent diabetic macular edema (DME) following anti-vascular endothelial growth factor (anti-VEGF) therapy for DME. Subsequently adding intravitreous corticosteroids to the treatment regimen might result in better outcomes tha ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · December 2017
PURPOSE: Vogt-Koyanagi-Harada (VKH) syndrome is a systemic inflammatory autoimmune disease with associated ophthalmic pathology. Glaucoma has been reported in patients with VKH. The purpose of this report is to examine the frequency and types of glaucoma a ...
Full textLink to itemCite
Journal articleOphthalmology · September 2017
PURPOSE: To report differences in visual acuities among patients with Coats' disease who sought treatment at a tertiary care university-based practice. DESIGN: Single-center retrospective cohort study. PARTICIPANTS: Patients with Coats' disease diagnosed c ...
Full textLink to itemCite
Journal articleOphthalmology · September 2017
PURPOSE: To compare the efficacy and safety of brolucizumab with aflibercept to treat neovascular age-related macular degeneration (AMD). DESIGN: Prospective, randomized, double-masked, multicenter, 2-arm, phase 2 study. PARTICIPANTS: Eighty-nine treatment ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 1, 2017
PURPOSE: The purpose of this study was to describe fundus autofluorescence (FAF) findings in eyes with birdshot chorioretinitis (BSCR) and to compare findings to demographic, medical, and clinical characteristics. METHODS: In this multicenter, prospective, ...
Full textLink to itemCite
Journal articleOphthalmology · June 2017
PURPOSE: To demonstrate the efficacy and safety of once-daily nepafenac 0.3% ophthalmic suspension versus vehicle, based on clinical outcomes, after cataract surgery in patients with diabetes. DESIGN: Two prospective, randomized, multicenter, double-masked ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · June 1, 2017
PURPOSE: Complement activation is implicated in the pathogenesis of age-related macular degeneration (AMD). Apolipoprotein E (ApoE) and complement activation products such as membrane attack complex (MAC) are present in eyes of individuals with AMD. Herein ...
Full textOpen AccessLink to itemCite
Journal articleAm J Ophthalmol · May 2017
PURPOSE: To determine whether disorganization of retinal inner layers (DRIL) assessed by spectral-domain optical coherence tomography (SDOCT) correlates with visual acuity (VA) in eyes with uveitic cystoid macular edema (CME). DESIGN: Secondary analysis of ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · May 1, 2017
PURPOSE: To correlate ellipsoid zone (EZ) defects on spectral-domain optical coherence tomography (SD-OCT) with retinal sensitivity loss on macular integrity assessment (MAIA) microperimetry in macular telangiectasia type 2 (MacTel). METHODS: Macular SD-OC ...
Full textLink to itemCite
Journal articleOphthalmology · April 2017
PURPOSE: To summarize the results of 2 consensus meetings (Classification of Atrophy Meeting [CAM]) on conventional and advanced imaging modalities used to detect and quantify atrophy due to late-stage non-neovascular and neovascular age-related macular de ...
Full textLink to itemCite
Journal articleLancet Neurol · March 2017
BACKGROUND: The human monoclonal antibody opicinumab (BIIB033, anti-LINGO-1) has shown remyelinating activity in preclinical studies. We therefore assessed the safety and tolerability, and efficacy of opicinumab given soon after a first acute optic neuriti ...
Full textLink to itemCite
Journal articleOphthalmology · February 2017
PURPOSE: To assess the safety and efficacy of E10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, administered in combination with the anti-vascular endothelial growth factor (VEGF) agent ranibizumab (Lucentis; R ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · February 2017
PURPOSE: We determine whether the automated segmentation software, Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP), can measure, in a platform-independent manner, retinal thickness on Cirrus and Spectralis spectral domain optical coher ...
Full textLink to itemCite
Journal articleOphthalmic Surg Lasers Imaging Retina · February 1, 2017
The authors describe three vitrectomized eyes that each subsequently developed a full-thickness macular hole (FTMH) that then spontaneously closed and summarize the current literature reporting these rare events. Clinical history, imaging, and course of th ...
Full textLink to itemCite
Journal articleOphthalmology · January 2017
PURPOSE: To estimate the incidence, size, and growth rate of geographic atrophy (GA) during 5 years of follow-up among participants in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Cohort within a clinical trial. PART ...
Full textLink to itemCite
Journal articleSurv Ophthalmol · 2017
Retinal angiomatous proliferation (RAP) is a unique variant of neovascular age-related macular degeneration. Published studies have estimated that up to 15% of patients with neovascular age-related macular degeneration have RAP. Clinical features frequentl ...
Full textLink to itemCite
Journal articleOphthalmol Retina · 2017
PURPOSE: To compare baseline characteristics, visual acuity (VA) and morphological outcomes between eyes with baseline hard exudates (HE) and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with anti-vascular ...
Full textLink to itemCite
Journal articleOphthalmol Retina · 2017
PURPOSE: To compare foveal anatomic features on OCT after macular hole (MH) closure, and their association with visual function, in the ocriplasmin phase III trials. DESIGN: Randomized clinical trial. PARTICIPANTS: One hundred fifty-three participants. MET ...
Full textLink to itemCite
Journal articleJ Ophthalmic Inflamm Infect · December 2016
BACKGROUND: The objective of this study is to describe a system for color photograph evaluation in uveitis and report baseline morphologic findings for the Multicenter Uveitis Steroid Treatment (MUST) Trial. Four-hundred seventy-nine eyes of 255 subjects w ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · October 2016
BACKGROUND/AIMS: To assess peripheral retinal lesions and the posterior pole in single widefield optical coherence tomography (OCT) volumes. METHODS: A wide field of view (FOV) swept-source OCT (WFOV SSOCT) system was developed using a commercial swept-sou ...
Full textLink to itemCite
Journal articleLancet · September 17, 2016
BACKGROUND: Non-infectious uveitis is a potentially sight-threatening ocular disorder caused by chronic inflammation and its complications. Therapeutic success is limited by systemic adverse effects associated with long-term corticosteroid and immunomodula ...
Full textLink to itemCite
Journal articleN Engl J Med · September 8, 2016
BACKGROUND: Patients with noninfectious uveitis are at risk for long-term complications of uncontrolled inflammation, as well as for the adverse effects of long-term glucocorticoid therapy. We conducted a trial to assess the efficacy and safety of adalimum ...
Full textLink to itemCite
Journal articleOphthalmology · September 2016
PURPOSE: To compare the effect of intravitreal aflibercept or ranibizumab drug type and frequency on visual acuity outcomes in eyes with neovascular age-related macular degeneration (NVAMD) and early persistent retinal fluid after 3 initial monthly injecti ...
Full textLink to itemCite
Journal articleOphthalmology · September 2016
PURPOSE: To determine the effect of an injectable fluocinolone acetonide implant (FAi) in eyes with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. DESIGN: Noncomparative, interventional, dose-randomized, dose-masked, prospective, ind ...
Full textLink to itemCite
Journal articleOphthalmology · August 2016
PURPOSE: To describe outcomes 5 years after initiating treatment with bevacizumab or ranibizumab for neovascular age-related macular degeneration (AMD). DESIGN: Cohort study. PARTICIPANTS: Patients enrolled in the Comparison of AMD Treatments Trials. METHO ...
Full textLink to itemCite
Journal articleOphthalmology · July 2016
PURPOSE: To compare the efficacy of intravitreal aflibercept and ranibizumab on the exudative activity of neovascular age-related macular degeneration (nAMD) using optical coherence tomography (OCT) and to correlate morphologic findings with visual acuity ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · July 1, 2016
PURPOSE: The purposes of this study were to describe choroidal findings observed using optical coherence tomography with enhanced depth imaging (EDI-OCT) in eyes with birdshot chorioretinitis (BSCR) and to test the hypothesis that these findings are relate ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · June 1, 2016
IMPORTANCE: Single-nucleotide polymorphisms (SNPs) associated with the CFH, ARMS2, C3, LIPC, CFB, and C2 genes are associated with age-related macular degeneration (AMD); however, the association of these SNPs with angiographic features of neovascular AMD ...
Full textLink to itemCite
Journal articleOphthalmology · April 2016
PURPOSE: To describe the association between morphologic features on fundus photography (FP), fluorescein angiography (FA), and optical coherence tomography (OCT) and visual acuity (VA) in the second year of the Comparison of Age-related Macular Degenerati ...
Full textLink to itemCite
Journal articleOphthalmology · April 2016
PURPOSE: To describe morphologic and visual outcomes in eyes with angiographic cystoid macular edema (CME) treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (nAMD). DESIGN: Prospective cohort study within a randomized ...
Full textLink to itemCite
Journal articleOphthalmology · April 2016
PURPOSE: To investigate the comparative efficacy of bevacizumab (Avastin) and ranibizumab (Lucentis; both Genentech, Inc, South San Francisco, CA) for diabetic macular edema (DME) using a crossover study design. DESIGN: Randomized, double-masked, 36-week, ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · April 1, 2016
PURPOSE: The purpose of this study was to investigate the presence, configuration, and progression of peripapillary atrophy (PPA) relative to macular geographic atrophy (GA) in AMD. METHODS: Confocal scanning laser ophthalmoscopy images of 413 eyes of 413 ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · April 2016
PURPOSE: To describe fluocinolone acetonide implant dissociations in the Multicenter Uveitis Steroid Treatment (MUST) Trial. DESIGN: Randomized clinical trial with extended follow-up. METHODS: Review of data collected on the first implant in the eye(s) of ...
Full textLink to itemCite
Journal articleOphthalmology · March 2016
PURPOSE: To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all other eyes among patients with neovascular age-related macular degeneration (NVAMD) treated with an ...
Full textLink to itemCite
Journal articleOphthalmology · February 2016
PURPOSE: The Geographic Atrophy Progression (GAP) study was designed to assess the rate of geographic atrophy (GA) progression and to identify prognostic factors by measuring the enlargement of the atrophic lesions using fundus autofluorescence (FAF) and c ...
Full textLink to itemCite
Journal articleOphthalmology · January 2016
PURPOSE: To assess the safety and tolerability of E10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, when administered in combination with an anti-vascular endothelial growth factor (VEGF) agent, ranibizumab (Lu ...
Full textLink to itemCite
Journal articleClin Ophthalmol · 2016
PURPOSE: The aims of this study were to determine the prevalence of vitreomacular adhesion (VMA) in a random sample of clinical patients at three US retina clinics and to assess comorbid retinal conditions, ocular diseases, prior treatment history, and oth ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · December 2015
PURPOSE: To determine the safety and efficacy of AL-8309B (tandospirone) in the management of patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) and obtain standardized data on GA lesion growth progression. DESIGN: Pr ...
Full textLink to itemCite
Journal articleOphthalmology · December 2015
PURPOSE: To evaluate the association of baseline characteristics and early visual acuity (VA) response with visual outcomes at years 1 or 2 in the Comparison of Age-Related Macular Degeneration (AMD) Treatments Trials (CATT). DESIGN: Secondary analysis of ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · December 2015
PURPOSE: To identify factors associated with best-corrected visual acuity (BCVA) presentation and 2-year outcome in 479 intermediate, posterior, and panuveitic eyes. DESIGN: Cohort study using randomized controlled trial data. METHODS: Multicenter Uveitis ...
Full textLink to itemCite
Journal articleOphthalmol Ther · December 2015
INTRODUCTION: The purpose of this study was to determine whether the outcomes following placement of a fluocinolone acetonide implant (Retisert(®); Bausch & Lomb, Inc.) combined with an Ahmed™ glaucoma valve (New World Medical, Inc.) in eyes with uveitic g ...
Full textLink to itemCite
Journal articleOphthalmology · November 2015
PURPOSE: To evaluate the 2-year outcomes of uveitic macular edema. DESIGN: Longitudinal follow-up of a randomized cohort. PARTICIPANTS: At baseline, 148 eyes of 117 patients enrolled in the Multicenter Uveitis Steroid Treatment (MUST) Trial had macular ede ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · October 2015
PURPOSE: To differentiate diabetic macular edema (DME) from pseudophakic cystoid macular edema (PCME) based solely on spectral-domain optical coherence tomography (SD-OCT). METHODS: This cross-sectional study included 134 participants: 49 with PCME, 60 wit ...
Full textLink to itemCite
Journal articleOphthalmology · September 2015
PURPOSE: To evaluate the association of subretinal hyperreflective material (SHRM) with visual acuity (VA), geographic atrophy (GA), and scar in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Prospective cohort study w ...
Full textLink to itemCite
Journal articleRetina · July 2015
PURPOSE: To examine treatment decisions by ophthalmologists versus reading center fluid identification from optical coherence tomography in Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). METHODS: Fluid in 6,210 optical coherence t ...
Full textLink to itemCite
Journal articleRetina · June 2015
PURPOSE: To evaluate visual function in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction including when associated with macular hole after ocriplasmin treatment, and the association between resolution of the underlying conditio ...
Full textLink to itemCite
Journal articleOphthalmology · June 2015
OBJECTIVE: To assess the association of the vitreomacular interface with outcomes of eyes treated with anti-vascular endothelial growth factor drugs for neovascular age-related macular degeneration (AMD). DESIGN: Prospective cohort study within a multicent ...
Full textLink to itemCite
Journal articleN Engl J Med · March 26, 2015
BACKGROUND: The relative efficacy and safety of intravitreous aflibercept, bevacizumab, and ranibizumab in the treatment of diabetic macular edema are unknown. METHODS: At 89 clinical sites, we randomly assigned 660 adults (mean age, 61±10 years) with diab ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · February 2015
PURPOSE: To assess the approach of specialists to ocular tuberculosis (TB). METHODS: The American Uveitis Society (AUS) Listserv was surveyed using two clinical cases and general questions. RESULTS: Of 196 members, 87 responded (44.4%), of whom 64 were aff ...
Full textLink to itemCite
Journal articleOphthalmology · January 2015
PURPOSE: To evaluate the efficacy of a single intravitreal injection of ocriplasmin 125 μg across relevant subpopulations of patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction (VMT), including when associated with macular hole. D ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · January 2015
PURPOSE: To evaluate the reproducibility of central subfield thickness (CST) and volume measurements from optical coherence tomography (OCT) images obtained with Zeiss Stratus and Optovue RTVue, and formulate equations to convert these measurements from RT ...
Full textLink to itemCite
Journal articleOphthalmology · November 2014
PURPOSE: A head-to-head comparison was performed between vascular endothelial growth factor blockade and laser for treatment of diabetic macular edema (DME). DESIGN: Two similarly designed, double-masked, randomized, phase 3 trials, VISTA(DME) and VIVID(DM ...
Full textLink to itemCite
Journal articleOphthalmology · October 2014
OBJECTIVE: To evaluate the 3-year incremental cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for the treatment of noninfectious intermediate, posterior, and panuveitis. DESIGN: Randomized, controlled, clinical trial. PARTICIPA ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · September 2014
IMPORTANCE: Understanding measurement variability and relationships between measurements obtained on different optical coherence tomography (OCT) machines is critical for clinical trials and clinical settings. OBJECTIVE: To evaluate the reproducibility of ...
Full textLink to itemCite
Journal articleLab Chip · August 7, 2014
We present a novel "Lab-on-a-Disk" platform and demonstrate its capability for rapid and sensitive measurement of vascular endothelial growth factor (VEGF) intended for patients suffering from diabetic retinopathy (DR) and age-related macular degeneration ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · August 2014
IMPORTANCE: Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of substantial vision can occur. Understanding the processes that lead to loss of vision m ...
Full textLink to itemCite
Journal articleJAMA Ophthalmol · July 2014
IMPORTANCE: Measurement of retinal nerve fiber layer (RNFL) thickness using optical coherence tomography can aid in the diagnosis and management of glaucoma. We observed a previously unreported phenomenon in eyes with uveitis-associated glaucoma in which p ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · May 6, 2014
PURPOSE: Retinal pigment epithelial (RPE) cell death is an important feature of the advanced forms of AMD. Complement alternative pathway (AP) activation is associated with RPE cell death in AMD. In this study, we developed a new model to initiate AP activ ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · November 15, 2013
PURPOSE: To determine whether a novel automatic segmentation program, the Duke Optical Coherence Tomography Retinal Analysis Program (DOCTRAP), can be applied to spectral-domain optical coherence tomography (SD-OCT) images obtained from different commercia ...
Full textLink to itemCite
Journal articleTransl Vis Sci Technol · November 2013
PURPOSE: To determine the impact of segmentation error correction and precision of standardized grading of time domain optical coherence tomography (OCT) scans obtained during an interventional study for macular edema secondary to central retinal vein occl ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · October 22, 2013
The aryl hydrocarbon receptor (AhR) is a nuclear receptor that regulates xenobiotic metabolism and detoxification. Herein, we report a previously undescribed role for the AhR signaling pathway as an essential defense mechanism in the pathogenesis of early ...
Full textLink to itemCite
Journal articleJournal of Medical Devices Transactions of the ASME · June 24, 2013
Microfluidic fluorescence assay devices show great promise as preclinical and clinical diagnostic instruments. Normally, fluorescence signals from microfluidic chips are quantified by analysis of images obtained with a commercial fluorescence microscope. T ...
Full textCite
Journal articleInvest Ophthalmol Vis Sci · June 10, 2013
PURPOSE: To characterize longitudinal changes of reticular drusen (RDR) in subjects with geographic atrophy (GA) secondary to age-related macular degeneration in the multicenter, prospective natural history Geographic Atrophy Progression Study. METHODS: Th ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · April 12, 2013
PURPOSE: Retinal pigment epithelial (RPE) cell death occurs early in the pathogenesis of age-related macular degeneration (AMD) and Stargardt's disease. Emerging evidence suggests that all-trans-retinal (atRal) and alternative complement pathway (AP) activ ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · December 13, 2012
PURPOSE: To evaluate macular thickness in people with diabetes but minimal or no retinopathy using Heidelberg Spectralis optical coherence tomography (OCT). METHODS: In a multicenter, cross-sectional study of mean retinal thickness, on Spectralis OCT in th ...
Full textLink to itemCite
Journal articleOphthalmology · December 2012
OBJECTIVE: To report reading center reproducibility during grading of Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Dublin, CA) images obtained during the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). DESIGN: Pr ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · October 25, 2012
PURPOSE: To determine the relative ability of time domain (TD)-optical coherence tomography (OCT) compared with spectral domain (SD)-OCT to assess vitreoretinal interface abnormalities and pharmacologic treatment of symptomatic vitreomacular adhesion (VMA) ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · September 21, 2012
PURPOSE: We determined the reproducibility of a novel optical coherence tomography (OCT) protocol designed to evaluate formally vitreoretinal interface abnormalities on scans obtained during two phase 3 studies of intravitreal ocriplasmin to treat symptoma ...
Full textLink to itemCite
Journal articleGraefes Arch Clin Exp Ophthalmol · September 2012
PURPOSE: Diagnostic vitrectomy is frequently used to help establish a diagnosis in challenging uveitis cases. The usefulness of this procedure in patients with suspected sarcoidosis with posterior segment involvement, in whom a diagnosis cannot be determin ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · July 26, 2012
PURPOSE: To determine the topographic distribution and progression of geographic atrophy (GA) in patients with AMD. METHODS: Fundus autofluorescence images (excitation 488, emission 500-700 nm) from 413 eyes of 413 subjects (median age, 77.0 years; inter q ...
Full textLink to itemCite
Journal articleOphthalmology · July 2012
OBJECTIVE: To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for 2 years and to describe the impact of switching to as-needed treatment after 1 year of monthly treatment. DESIGN: Multicenter, randomized clinical tria ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · June 2012
PURPOSE: To evaluate the impact of macular edema on visual acuity and visual field sensitivity in uveitis. DESIGN: This study utilized baseline data from the Multicenter Uveitis Steroid Treatment (MUST) Trial, a randomized, parallel treatment clinical tria ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · April 2012
PURPOSE: To assess the prevalence of hypotony in patients with severe forms of uveitis. METHODS: The Multicenter Uveitis Steroid Treatment (MUST) Trial, a randomized study, enrolled 255 patients. Patients with hypotony at the baseline visit were identified ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · March 2012
PURPOSE: To evaluate the associations between visual acuity and self-reported visual function; visual acuity and health-related quality of life (QoL) metrics; a summary measure of self-reported visual function and health-related QoL; and individual domains ...
Full textLink to itemCite
Journal articleOphthalmology · January 2012
PURPOSE: To assess long-term visual outcomes and adverse events from a fluocinolone acetonide (FA) sustained drug delivery implant in eyes with chronic macular edema from central retinal vein occlusion (CRVO). DESIGN: Prospective interventional case series ...
Full textLink to itemCite
Journal articleClin Ophthalmol · 2012
BACKGROUND: The purpose of this study was to evaluate nepafenac ophthalmic suspension 0.1% (Nevanac(®); Alcon Research Ltd) in the prevention of macular edema following cataract surgery in diabetic retinopathy patients. METHODS: This was a multicenter, ran ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · November 2011
PURPOSE: To assess the feasibility and outcomes of combining fluocinolone acetonide sustained drug delivery implant insertion, pars plana vitrectomy, and silicone oil infusion to treat patients with chronic, refractory ocular hypotony resulting from uveiti ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · October 2011
PURPOSE: To review current evidence for the treatment of ocular toxoplasmosis (OT). DESIGN: Narrative review and expert recommendations. METHODS: Meta-analysis and selected original articles from the medical literature were reviewed critically. Expert reco ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · September 29, 2011
PURPOSE: To determine intraobserver and interobserver longitudinal measurement variability of novel semiautomated software for quantification of age-related macular degeneration-associated geographic atrophy (GA) based on confocal scanning laser ophthalmos ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 24, 2011
PURPOSE: To characterize reticular drusen (RDR) in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in a prospective, multicenter, natural history study. METHODS: Confocal scanning laser ophthalmoscopy (cSLO) three- ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 17, 2011
PURPOSE. Retinal pigment epithelial (RPE) cell survival plays a critical role in normal physiology and in retinal diseases, such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). We have previously demonstrated that Bcl-x ...
Full textLink to itemCite
Journal articleOcul Immunol Inflamm · August 2011
PURPOSE: To compare Reading Center (RC) cup-to-disc ratio (CDR) assessment from stereoscopic photographs with clinician estimation in a uveitis clinical trial. METHODS: Clinical estimation of CDR was performed by ophthalmologists via dilated biomicroscopy. ...
Full textLink to itemCite
Journal articleN Engl J Med · May 19, 2011
BACKGROUND: Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. METHO ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · April 12, 2011
There is no treatment available for vision loss associated with advanced dry age-related macular degeneration (AMD) or geographic atrophy (GA). In a pilot, proof of concept phase 2 study, we evaluated ciliary neurotrophic factor (CNTF) delivered via an int ...
Full textLink to itemCite
Journal articleOphthalmology · June 2010
PURPOSE: To characterize the types and frequencies of image artifacts associated with macular scanning using 2 common spectral-domain optical coherence tomography (SD OCT) instruments and to evaluate the impact of artifacts on foveal thickness measurements ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · May 2010
PURPOSE: To determine whether a fluocinolone acetonide sustained-release intravitreal drug delivery system can be implanted safely at the same time that a glaucoma drainage device is placed for eyes with uveitis and elevated intraocular pressure (IOP) rece ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · April 2010
PURPOSE: To describe the design and methods of the Multicenter Uveitis Steroid Treatment (MUST) trial and the baseline characteristics of enrolled patients. DESIGN: Baseline data from a 1:1 randomized, parallel treatment design clinical trial at 23 clinica ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · September 2009
PURPOSE: To determine the frequency of retinal thickening (RT) in eyes with iridocyclitis and to examine the correlations among anterior chamber (AC) inflammation, RT, and visual acuity. DESIGN: Retrospective, observational case series. METHODS: Records we ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · July 2009
PURPOSE: Complement, inflammation, and oxidant injury contribute to age-related macular degeneration (AMD). Membrane complement regulatory proteins (mCRPs) such as CD46, CD55, and CD59, protect host cells from complement attack. The factors that regulate R ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · May 2009
PURPOSE: To compare retinal thickness (RT) measurements obtained by spectral-domain optical coherence tomography (SD-OCT) and time-domain OCT (TD-OCT) in eyes with and without posterior segment disease diagnoses. DESIGN: Retrospective, observational chart ...
Full textLink to itemCite
Journal articleRetina · February 2009
PURPOSE: To compare the incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide injections during a 6 month period in 2006 to the same period in 2005 and determine the incidence after switching to intravitreal preservative-free tria ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 2008
PURPOSE: To determine whether a three-year fluocinolone acetonide sustained drug delivery system can be implanted safely at the same time that phacoemulsification and intraocular lens (IOL) implantation are performed for a visually significant cataract in ...
Full textLink to itemCite
Journal articleArch Ophthalmol · September 2008
OBJECTIVES: To evaluate the safety and efficacy of 0.59-mg and 2.1-mg fluocinolone acetonide (FA) intravitreous implants in noninfectious posterior uveitis. DESIGN: A 3-year, multicenter, randomized, historically controlled trial of the 0.59-mg FA intravit ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · August 2008
PURPOSE: To determine treatment outcomes of a long-acting intravitreal fluocinolone acetonide sustained drug delivery implant in eyes with central retinal vein occlusion (CRVO) and chronic refractory macular edema. DESIGN: Prospective, noncomparative, inte ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · April 2008
PURPOSE: To determine the effects of a second fluocinolone implant inserted in eyes with uveitis in which recurrent inflammation developed after the original implant was placed. DESIGN: Prospective, interventional trial. METHODS: Study subjects comprised a ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · December 2007
PURPOSE: To assess a response to infliximab therapy in childhood uveitis. DESIGN: Retrospective case series. METHODS: We reviewed the course of 16 children with noninfectious uveitis treated with infliximab at an academic medical center. Outcome measures i ...
Full textLink to itemCite
Journal articleArch Ophthalmol · November 2007
OBJECTIVE: To report the incidence and management of elevated intraocular pressure (IOP) in patients with uveitis treated with the fluocinolone acetonide (FA) intravitreal implant. DESIGN: Pooled data from 3 multicenter, double-masked, randomized, controll ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 2007
PURPOSE: In normal eyes and in diseases such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR), retinal pigment epithelial (RPE) cell survival is critically important. Bcl-x(L) has been shown to be among the most highly ex ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · July 2007
PURPOSE: To determine the interreader and intrareader agreement at the Optical Coherence Tomography (OCT) Reading Center at Duke for images produced for an interventional neovascular age-related macular degeneration (AMD) clinical trial. DESIGN: Retrospect ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · July 2007
PURPOSE: Tumor necrosis factor (TNF)-alpha is an important cytokine associated with age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). TNF-alpha activates the extrinsic apoptotic pathway. In many cells, nuclear transcription ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · October 2006
PURPOSE: To determine whether a model oxidant, hydrogen peroxide (H2O2), influences Akt activation and, if so, whether Akt activation promotes retinal pigment epithelial (RPE) cell survival. METHODS: Cultured human RPE cells were pretreated with medium alo ...
Full textLink to itemCite
Journal articleArch Ophthalmol · July 2006
OBJECTIVE: To determine the efficacy of 0.5-mg and 0.1-mg sustained-release fluocinolone acetonide intravitreal implants to inhibit ocular inflammation in a rabbit model of severe uveitis. METHODS: The in vitro pharmacokinetic profile of both the 0.5-mg an ...
Full textLink to itemCite
Journal articleOphthalmology · June 2006
PURPOSE: To report the interim 34-week safety and efficacy results of a 3-year study to evaluate an investigational intravitreal fluocinolone acetonide (FA) implant in patients with noninfectious posterior uveitis. DESIGN: Prospective, dose-masked, dose-ra ...
Full textLink to itemCite
Journal articleExp Eye Res · April 2006
Cultured retinal pigment epithelial (RPE) cells are commonly used as a model of the tissue to study their involvement in visual diseases. Unfortunately, cultured RPE often lose their differentiated phenotype reducing their usefulness as a model of the RPE ...
Full textLink to itemCite
Journal articleOphthalmology · February 2006
PURPOSE: There is a paucity of population-based data on the epidemiology of uveitis in the elderly. In the past 40 years, only 2 U.S. population-based studies have examined the epidemiology of uveitis. The conclusions of these studies on the burden of uvei ...
Full textLink to itemCite
Journal articleOphthalmology · December 2005
PURPOSE: To describe the clinical features and management of the largest reported series to date of patients with diffuse unilateral subacute neuroretinitis (DUSN). DESIGN: Observational case series. METHODS: The charts of all patients coded as having DUSN ...
Full textLink to itemCite
Journal articleArch Pathol Lab Med · August 2005
We report a primary intraocular T-cell-rich large B-cell lymphoma in a 57-year-old woman who underwent 3 diagnostic vitrectomies for a presumed diagnosis of panuveitis. She developed no light perception in the left eye and underwent enucleation. Histopatho ...
Full textLink to itemCite
Journal articleOphthalmology · July 2005
PURPOSE: To investigate the safety and efficacy of a fluocinolone acetonide intravitreal implant in the treatment of noninfectious posterior uveitis. DESIGN: Noncomparative interventional case series, dose randomized, dose masked, prospective. PARTICIPANTS ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · May 2005
PURPOSE: To determine basal and tumor necrosis factor (TNF)-alpha-regulated expression of retinal pigment epithelial (RPE) cell survival factors and whether regulation is dependent on nuclear transcription factor (NF)-kappaB. METHODS: Cultured human RPE ce ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · January 2005
PURPOSE: To determine the frequency and type of optical coherence tomography (OCT) fast macular thickness map (FMTM) scan artifacts, and whether these artifacts depend on patient diagnosis, demographics, and ocular therapy. DESIGN: Retrospective observatio ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · July 2004
PURPOSE: In many cell types, tumor necrosis factor (TNF)-alpha-induced apoptosis is prevented by production of TNF-alpha-induced antiapoptotic protein, a process mediated by nuclear transcription factor (NF)-kappa B. TNF-alpha is widely expressed in prolif ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · June 2004
PURPOSE: To determine the prevalence of and risk factors for proliferatative vitreoretinopathy (PVR) in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. DESIGN: Observational case series. METHODS: Prospective study. SETTIN ...
Full textLink to itemCite
Journal articleOphthalmology · February 2004
OBJECTIVE: To compare the frequency of posterior segment involvement (PSI), the prevalence of specific posterior segment signs, and visual acuity in ocular sarcoidosis by patient race, sex, and age. DESIGN: Retrospective, cross-sectional observational stud ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · January 2004
PURPOSE: To review basic principles of optical coherence tomography, and to describe its use in the diagnosis and management of retinal diseases and glaucoma. DESIGN: Perspective. METHODS: Literature review. RESULTS: Optical coherence tomography is a nonin ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · September 2003
PURPOSE: To evaluate treatment of cystoid macular edema associated with central retinal vein occlusion with intravitreal triamcinolone acetonide. METHODS: This study included 10 eyes of nine patients with perfused central retinal vein occlusion with visual ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · July 2003
Featured Publication
PURPOSE: To report the sensitivity and specificity of B-scan ultrasonography to detect macular thickening. DESIGN: Observational case series. METHODS: Seventy-seven eyes of 40 consecutive patients (age range, 7-80 years) in a retinal specialty practice wer ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · June 2003
Featured Publication
PURPOSE: Aquaporin (AQP) is a hexahelical integral membrane protein that functions as a constitutive channel for water and regulated channel for cations in fluid transporting tissues, including many in the eye. Although AQP1 has been cloned from a cDNA lib ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · March 2003
Featured Publication
PURPOSE: The nuclear transcription factor (NF)-kappaB is a central regulator of multiple inflammatory cytokines. The current study was conducted to determine whether infection of human retinal pigment epithelial (RPE) cells by adenovirus carrying a mutant ...
Full textLink to itemCite
Journal articleRetina · February 2003
Featured Publication
PURPOSE: To describe the results of a modified external needle subretinal fluid drainage technique to treat eyes with a rhegmatogenous retinal detachment. METHODS: One hundred eighty-seven consecutive patients with a rhegmatogenous retinal detachment who u ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · November 2002
Featured Publication
PURPOSE: To evaluate the effects of subretinal and intravitreal delivery of INS37217, a P2Y(2) receptor agonist, on subretinal fluid reabsorption in experimentally induced retinal detachments in rabbits, and to characterize the effects of INS37217 on elect ...
Link to itemCite
Journal articleAm J Vet Res · July 2002
OBJECTIVE: To determine whether a chemokine (RANTES)-like protein expressed by ciliary epithelium plays a role in uveitis. SAMPLE POPULATION: 3 clinically normal horses intradermal, 5 eyes from 5 horses with recurrent uveitis, and 10 normal eyes from 5 age ...
Full textLink to itemCite
Journal articleOphthalmology · June 2002
Featured Publication
PURPOSE: To determine the yield of diagnostic pars plana vitrectomy in eyes with suspected posterior segment inflammation or malignancy when clinical examination and systemic laboratory testing did not yield a specific diagnosis. DESIGN: Non-comparative in ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · February 2001
PURPOSE: To evaluate a new procedure for displacement of large, thick submacular hemorrhage in patients with age-related macular degeneration. METHODS: Retrospective review of 11 eyes of 11 patients with age-related macular degeneration and thick submacula ...
Full textLink to itemCite
Journal articleRetina · 2001
PURPOSE: Ganciclovir (GCV) implants are highly effective in delaying the progression of cytomegalovirus (CMV) retinitis. Rhegmatogenous retinal detachments can occur in untreated eyes with CMV retinitis or in eyes treated with anti-CMV therapy, which may i ...
Full textLink to itemCite
Journal articleRetina · 2001
PURPOSE: To describe the characteristics, treatment, and outcome of five eyes with both choroidal neovascularization (CNV) and macular hole. METHODS: Medical records of five patients with both macular hole and CNV were reviewed. RESULTS: All eyes had full- ...
Full textLink to itemCite
Journal articleOphthalmology · November 2000
Featured Publication
PURPOSE: Uveitis is often a chronic disease requiring long-term medical therapy. In this report, we describe a pilot safety and efficacy trial of a novel sustained drug delivery system containing fluocinolone acetonide to treat patients with severe uveitis ...
Full textLink to itemCite
Journal articleVet Immunol Immunopathol · October 31, 2000
The purpose of this study was to determine the effects of an intravitreal device releasing cyclosporine A (CsA) on recurrent inflammatory episodes in experimental uveitis. Nine normal horses were immunized peripherally with H37RA-mTB antigen twice, and the ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · October 2000
Featured Publication
PURPOSE: To determine the safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained drug delivery device. METHODS: Nonbiodegradable drug delivery devices containing 2 or 15 mg of a synthetic corticosteroid, fluocinolone acetonide, were ...
Link to itemCite
Journal articleAm J Ophthalmol · October 2000
PURPOSE: To provide recommendations for the use of immunosuppressive drugs in the treatment of patients with ocular inflammatory disorders. PARTICIPANTS: A 12-person panel of physicians with expertise in ophthalmologic, pediatric, and rheumatologic disease ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 2000
PURPOSE: To report complications and changes in vision during 2 years of follow-up of patients with age-related macular degeneration assigned randomly to surgical removal or to laser photocoagulation of subfoveal recurrent neovascular lesions in a pilot tr ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 2000
PURPOSE: To summarize findings from health-related quality-of-life interviews with patients who had recurrent subfoveal choroidal neovascularization secondary to age-related macular degeneration and participated in a randomized pilot trial (focal confluent ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · August 2000
PURPOSE: To report two cases in which a bull's eye maculopathy developed after intravitreal injection of fomivirsen. METHODS: Case reports. RESULTS: A 50-year-old man with acquired immunodeficiency syndrome (AIDS) and refractory cytomegalovirus retinitis d ...
Full textLink to itemCite
Journal articleRetina · 2000
PURPOSE: To study the results of modern vitrectomy in traction and combined traction-rhegmatogenous retinal detachment involving the macula in cases of ocular toxocariasis. METHODS: This was a cohort study of patients seen in different institutions in the ...
Full textLink to itemCite
Journal articleRetina · 2000
PURPOSE: To determine the effect of intraocular gas tamponade on drug levels achieved with the intravitreal sustained-release fluocinolone (FL)/5-fluorouracil (5-FU) codrug pellet. METHODS: After insertion of a 10-mg codrug pellet into the right eyes of 43 ...
Full textLink to itemCite
Journal articleRetina · 2000
PURPOSE: To describe three cases of exudative retinal detachment and focal retinitis associated with acquired syphilitic uveitis. METHODS: Three patients who were referred for evaluation of uveitis were examined. Slit-lamp examination, ophthalmoscopy, B-sc ...
Link to itemCite
Journal articleVet Ophthalmol · 2000
OBJECTIVE: To determine the long-term toxicity of an intravitreal device releasing continuous cyclosporinee A (CsA) in normal eyes of horses by evaluating clinical signs, electroretinography, and histopathology. Animals Studied Ten adult horses with normal ...
Full textLink to itemCite
Journal articleRetina · 2000
PURPOSE: To compare the relative incidence of vitreoretinal adhesions associated with partial vitreous separation within the macula diagnosed with optical coherence tomography (OCT) with that of those diagnosed with biomicroscopy. METHODS: The authors obta ...
Link to itemCite
Journal articleOphthalmology · November 1999
OBJECTIVE: To test the hypothesis that pretreatment fluorescein angiography (FA) is not necessary for effective laser treatment of patients with clinically significant diabetic macular edema (CSME). DESIGN: Prospective, randomized, controlled treatment sim ...
Full textLink to itemCite
Journal articleOphthalmology · August 1999
OBJECTIVE: To report a cohort of patients in whom polymerase chain reaction (PCR) was performed on vitreous samples and to place in perspective the current role of PCR in the diagnosis of ocular toxoplasmosis. DESIGN: Noncomparative case series. PARTICIPAN ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · March 1999
PURPOSE: To describe the risks, benefits, and recommended use of the ganciclovir implant for the treatment of human immunodeficiency virus-related cytomegalovirus (CMV) retinitis in the era of potent antiretroviral therapy. METHODS: A panel of physicians w ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · February 1999
PURPOSE: To determine whether nuclear transcription factor-kappaB (NF-kappaB) is activated in human retinal pigment epithelial (hRPE) cells in response to interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), or interferon-gamma (IFN-gamma ...
Link to itemCite
Journal articleOphthalmology · January 1999
OBJECTIVE: To report the results of a phase I trial to evaluate the safety and efficacy of atovaquone for the treatment of ocular toxoplasmosis in immunocompetent patients. DESIGN: Open label, nonrandomized, prospective, clinical trial. PARTICIPANTS: Seven ...
Full textLink to itemCite
Journal articleOphthalmology · January 1999
OBJECTIVE: To determine the safety and efficacy of low-dose methotrexate (MTX) for sarcoid-associated panuveitis. DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Twenty eyes from 11 patients were analyzed. Eight patients had sarcoidosis. Th ...
Full textLink to itemCite
Journal articleOphthalmology · November 1998
OBJECTIVE: To describe the management of complications in eyes containing two intraocular lenses (IOLs). DESIGN: A retrospective noncomparative case series. PARTICIPANTS: Eight patients having a dislocated posterior chamber intraocular lens (PC IOL) and a ...
Full textLink to itemCite
Journal articleOphthalmology · July 1998
OBJECTIVE: Silicone oil frequently is used as a vitreous substitute after complex vitreoretinal procedures. The authors sought to study the effect of short- and long-term exposure to silicone oil on polymethyl methacrylate (PMMA, MC60BM; Alcon, Ft. Worth, ...
Full textLink to itemCite
Journal articleArch Ophthalmol · January 1998
Featured Publication
OBJECTIVE: To determine the efficacy and pharmacokinetics of an intravitreal sustained-release triamcinolone acetonide and 5-fluorouracil (TA/5-FU) codrug in the treatment of experimental proliferative vitreoretinopathy (PVR). METHODS: The therapeutic effi ...
Full textLink to itemCite
Journal articleOphthalmology · January 1998
Featured Publication
OBJECTIVE: Uveitis often is a chronic disease requiring long-term medical therapy. Despite treatment, the disease may be difficult to control and may produce serious, vision-threatening ocular complications. In this study, the authors determined whether an ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · November 1997
PURPOSE: To describe the management of condensation on the posterior surface of a foldable acrylic intraocular lens during vitrectomy and fluid-air exchange. METHODS: A 70-year-old pseudophakic man with a foldable acrylic intraocular lens and open posterio ...
Full textLink to itemCite
Journal articleCurr Eye Res · September 1997
Featured Publication
PURPOSE: Previous epidemiologic studies of uveitis have focused on predominantly Caucasian populations, and none have been based in the Southeast. We analyzed the epidemiology of uveitis among a referral population with a high percentage of African America ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · September 1997
Featured Publication
PURPOSE: CD44 is a major hyaluronic acid receptor that exists as a number of isoforms, generated by alternative splicing of 9 "variant" exons in humans (v2 to v10) and 10 exons in rodents. Little is known about the expression and function of CD44 in human ...
Link to itemCite
Journal articleAm J Ophthalmol · March 1997
PURPOSE: To examine the behavior of surgically repaired macular holes when subsequent retinal detachment with submacular fluid develops and to correlate these observations with current theories of macular hole formation and closure. METHODS: We reviewed th ...
Full textLink to itemCite
Journal articleOphthalmology · January 1997
BACKGROUND: The diagnosis of toxoplasmic retinochoroiditis is based primarily on characteristic ocular findings, with supportive serologic evidence. Clinical recognition of atypical presentations is critical for timely antiparasitic drug therapy. METHODS: ...
Full textLink to itemCite
Journal articleCurr Eye Res · October 1996
PURPOSE: Antitransferrin receptor immunotoxin has potent antiproliferative effects on proliferating human ocular cells in vitro, and shows promise in the treatment of ocular proliferative diseases, such as proliferative vitreoretinopathy, bleb scarring aft ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · October 1996
PURPOSE: Proliferative vitreoretinopathy (PVR) remains the most common cause of failed retinal detachment (RD) surgery. The authors compared the effectiveness of two intraocular sustained-release codrugs in suppressing PVR in a rabbit model a surgically im ...
Link to itemCite
Journal articleOphthalmology · September 1996
PURPOSE: Condensation occurs rapidly on silicone intraocular lenses (IOLs) after vitrectomy and fluid-air exchange in the presence of a posterior capsulotomy, severely limiting the retinal view. Foldable IOLs made of an acrylic polymer are now available. T ...
Full textLink to itemCite
Journal articleBone Marrow Transplant · July 1996
A 49-year-old woman received an autologous transplant for breast cancer. Six weeks later she noticed visual disturbance of the left eye which correlated with a visual field abnormality. There was a milder degree of visual disturbance in the right eye. Trea ...
Link to itemCite
Journal articleExp Eye Res · June 1996
This study was designed to determine the safety and efficacy of transferrin-ricin A chain toxin (Tfr-rRA) at preventing retinal detachment in a rabbit model of proliferative vitreoretinopathy (PVR). The toxicity of intravitreal Tfr-rRA (1000-5000 ng) was d ...
Full textLink to itemCite
Journal articleCurr Eye Res · May 1996
PURPOSE: A device that releases cyclosporine and dexamethasone into the eye for extended periods of time might be beneficial in diseases such as proliferative vitreoretinopathy and uveitis. In this study we examine the pharmacokinetics and toxicity of cycl ...
Full textLink to itemCite
Journal articleArch Ophthalmol · March 1996
OBJECTIVES: To examine the clearance of cyclosporine after intravitreal injection and to assess the kinetics and toxic effects of an intravitreal device that provides sustained delivery of cyclosporine. METHODS: Rabbits were divided into two groups to eval ...
Full textLink to itemCite
Journal articleOphthalmology · February 1996
PURPOSE: An inferior peripheral iridectomy (IPI) was used to prevent forward migration of silicone oil in vitrectomized eyes; however, in approximately one third of eyes, the IPI closed spontaneously. Occlusion of the IPI by fibrin is believed to be an ear ...
Full textLink to itemCite
Journal articleRetina · 1996
BACKGROUND: Patients with intraocular involvement by Hodgkin's disease may present with a variety of ocular abnormalities. Intraocular infections also have been reported in these patients, including two cases of cytomegalovirus retinitis (CMV) diagnosed on ...
Full textLink to itemCite
Journal articleOphthalmology · January 1996
PURPOSE: To characterize the ocular toxicity of a bone marrow transplant regimen does not include total body or focal head irradiation. METHODS: Nine patients with advanced breast cancer were referred for visual symptoms after high-dose chemotherapy with c ...
Full textLink to itemCite
Journal articleGraefes Arch Clin Exp Ophthalmol · January 1996
BACKGROUND: Although the mechanism of preretinal neovascular growth in the cell-injected rabbit eye model is not known, it has been proposed that the initial vasodilation and eventual development of neovascularization may be attributable to inflammatory me ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · January 1996
PURPOSE: To alert ophthalmologists that prolonged or severe postoperative periocular pain and nausea may be caused by migraine. METHODS: We examined two patients who had a history of migraine and had severe episodes of prolonged periocular pain and nausea ...
Full textLink to itemCite
Journal articleCurr Eye Res · November 1995
We determined whether interleukin-8, monocyte chemotactic protein-1, and macrophage-colony stimulating factor are present in the vitreous of patients with proliferative diabetic retinopathy (PDR) or proliferative vitreoretinopathy (PVR). The levels of thes ...
Full textLink to itemCite
Journal articleExp Eye Res · May 1995
In retinal pigment epithelium, apically applied epinephrine changes the conductance of specific ions which subsequently affects the membrane voltage and stimulates transepithelial fluid transport. In this investigation, myo-[3H]inositol radiotracer studies ...
Full textLink to itemCite
Journal articleOphthalmology · May 1995
PURPOSE: Posterior chamber foldable silicone intraocular lenses (IOLs) are becoming increasingly prevalent in patients undergoing a pars plana vitrectomy with fluid-air exchange. The authors report an important limitation of foldable silicone IOLs during f ...
Full textLink to itemCite
Journal articleExp Eye Res · May 1995
Monocytes and retinal pigment epithelial cells are intimately associated in membranes of eyes with proliferative vitreoretinopathy and in certain types of uveitis. The goal of this study was to determine whether monocytes modulate cytokine expression in re ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · February 1995
PURPOSE: Uveitis often runs a chronic course requiring long-term therapy. Topical treatment results in poor intravitreal penetration, and systemic therapy is associated with significant side effects. The authors investigated whether an intravitreal sustain ...
Link to itemCite
Journal articleRetina · 1995
PURPOSE: To describe the clinical characteristics of the vitreomacular traction syndrome with macular detachment and to report our surgical experience with this condition. METHODS: A retrospective chart and photographic review was performed on nine patient ...
Full textLink to itemCite
Journal articleRetina · 1995
BACKGROUND: The morphologic features and clinical consequences of removing residual optic disc stalks during vitrectomy for complications of diabetic retinopathy have not been described. METHODS: Twenty-four residual optic disc stalks that were surgically ...
Full textLink to itemCite
Journal articleJ Cataract Refract Surg · September 1994
We investigated the effect of an antitransferrin receptor immunotoxin (454A12-rRA) on proliferating human and baboon lens epithelium in vitro. Human and baboon lens epithelial cells grown in modified TC-199 medium at 35 degrees Celsius in 7% CO2 were seede ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · June 1994
PURPOSE: To determine whether human retinal pigment epithelial (hRPE) cells produce activin, a growth factor in the transforming growth factor beta family, and to characterize growth regulatory effects of activin on retinal pigment epithelium. METHODS: mRN ...
Link to itemCite
Journal articleAm J Ophthalmol · February 15, 1994
Eight eyes (seven patients) with traumatic chorioretinal rupture (sclopetaria) from severe ocular trauma were examined. All seven patients were referred with diagnoses of retinal detachment, giant retinal tear, or ruptured globe. Instead, all eyes had larg ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · February 1994
PURPOSE: To examine the antiproliferative and lysyl hydroxylase suppressing effects of 3'-hydroxyminoxidil and 4'-hydroxyminoxidil, derivatives of minoxidil devoid of the antihypertensive effect, on human retinal pigment epithelial (RPE) cells in culture. ...
Link to itemCite
Journal articleRetina · 1994
PURPOSE: To determine whether postvitrectomy fibrin formation was associated with visual outcome, a prospective study of patients undergoing pars plana vitrectomy was performed. METHODS: In 121 patients undergoing vitrectomy at the Medical College of Wisco ...
Full textLink to itemCite
Journal articleJ Ocul Pharmacol · 1994
An implantable sustained release device has been developed to treat chronic disorders of the eye. The device, consisting of a central core of drug encased in layers of permeable and impermeable polymers, can be implanted subconjunctivally or intravitreally ...
Full textLink to itemCite
Journal articleRetina · 1994
BACKGROUND: Lightning can cause a number of ocular complications. A case involving a patient who developed a cataract and reversible maculopathy in both eyes after being struck by lightning is reported. METHODS: The patient was evaluated for cataract and m ...
Link to itemCite
Journal articleMol Cell Biol · January 1994
We have characterized constitutive and cytokine-regulated MGSA/GRO alpha, -beta, and -gamma gene expression in normal retinal pigment epithelial (RPE) cells and a malignant melanoma cell line (Hs294T) to discern the mechanism for MGSA/GRO constitutive expr ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · November 1993
PURPOSE: To determine the effect of a rabbit transferrin conjugated to recombinant ricin A chain (Tfr-rRA) and the carboxylic ionophore monensin on proliferating and density-arrested human retinal pigment epithelial cells and rabbit dermal fibroblasts. MET ...
Link to itemCite
Journal articleInvest Ophthalmol Vis Sci · August 1993
PURPOSE: To characterize mRNA expression and protein production of the cytokine MGSA/gro in human retinal pigment epithelial (RPE) cells and to determine whether expression of MGSA/gro is modulated by serum and the cytokines interleukin 1 beta (IL-1 beta), ...
Link to itemCite
Journal articleInvest Ophthalmol Vis Sci · March 1993
PURPOSE: To examine the antiproliferative and lysyl hydroxylase-suppressing effects of minoxidil on cultured proliferating and density-arrested human retinal pigment epithelial cells (hRPE) and Tenon's capsule fibroblasts (hTCF). METHODS: Proliferating and ...
Link to itemCite
Journal articleCurr Eye Res · January 1993
The effect of monensin on the cytotoxic effect of antitransferrin receptor immunotoxin (IT) was determined on cultured, human retinal pigment epithelial (hRPE) cells. Human RPE cells were treated with 0.1-10,000 ng/ml IT with and without 0.01-0.1 microM mo ...
Full textLink to itemCite
Journal articleExp Cell Res · November 1992
The ionic environment of retinal photoreceptors is partially controlled by potassium transporters on retinal glial and retinal pigment epithelial cells (RPE). In this study, serum and epidermal growth factor (EGF) were examined as modulators of potassium t ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 15, 1992
Twenty-one patients with symmetric nonproliferative retinopathy who underwent extracapsular cataract extraction and intraocular lens implantation were followed up postoperatively for an average (+/- standard deviation) of 18 +/- 7 months to determine the i ...
Full textLink to itemCite
Journal articleCornea · September 1992
We examined the effects of the immunotoxin 454A12-rRa on proliferating and confluent human corneal epithelium (HCE) in vitro. Proliferating HCE was sensitive to 454A12-rRA in a dose-dependent fashion. At immunotoxin concentrations of 1,000 ng/ml for 7 days ...
Full textLink to itemCite
Journal articleExp Eye Res · August 1992
mRNA expression and protein production of interleukin-1 alpha, interleukin-1 beta and intracellular and secreted forms of an interleukin-1 receptor antagonist were measured in visually confluent monolayers of unstimulated cultured human retinal pigment epi ...
Full textLink to itemCite
Journal articleArch Ophthalmol · June 1992
Between September 1985 and September 1987, 101 eyes with rhegmatogenous retinal detachment and severe (with a classification of at least C-3) proliferative vitreoretinopathy but without prior vitrectomy were treated with vitrectomy and randomized to either ...
Full textLink to itemCite
Journal articleArch Ophthalmol · June 1992
Between September 1987 and October 1990, 265 eyes with rhegmatogenous retinal detachment and severe (with a classification of at least C-3) proliferative vitreoretinopathy were treated with vitrectomy and randomized to treatment with perfluoropropane gas o ...
Full textLink to itemCite
Journal articleExp Eye Res · April 1992
Steady-state mRNA expression and protein production of macrophage colony stimulating factor were measured in visually confluent monolayers of unstimulated cultured human retinal pigment epithelial cells and after cells were stimulated with recombinant cyto ...
Full textLink to itemCite
Journal articleRefract Corneal Surg · 1992
BACKGROUND: Postoperative fibrin formation remains a major complication associated with intraocular surgery, especially after vitreoretinal surgery for proliferative vitreoretinopathy, proliferative diabetic retinopathy, trauma, or endophthalmitis. Tissue ...
Link to itemCite
Journal articleGynecol Oncol · August 1991
The cytokine interleukin-1 (IL-1) can inhibit growth of breast cancer cells in culture and promote cellular differentiation in synergism with other growth factors. A secreted IL-1 receptor antagonist (sIL-1ra) has been described and an intracellular versio ...
Full textLink to itemCite
Journal articleInvest Ophthalmol Vis Sci · June 1991
The density of Na/K adenosine triphosphatase (ATPase) pumps in retinal pigment epithelial (RPE) cells in different retinal regions was quantified by measuring the binding of 3H-ouabain to RPE in cow and human eyecups. In bovine eyes, pump density was estim ...
Link to itemCite
Journal articleExp Cell Res · June 1991
The number and activity of ouabain-sensitive Na/K ATPase pumps expressed by many cell types in vitro, including human retinal pigment epithelial cells (RPE), have been shown to decline with increasing culture density. Cell proliferation also declined as cu ...
Full textLink to itemCite
Journal articleProc Natl Acad Sci U S A · May 1, 1991
A cDNA encoding a receptor antagonist of interleukin 1 (IL-1ra), secreted from human monocytes, has recently been isolated and sequenced [Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H. & Thompson, R. C. (1990) Nat ...
Full textLink to itemCite
Journal articleArch Ophthalmol · August 1990
Cultured human retinal pigment epithelial cells were exposed to an immunotoxin composed of a monoclonal antibody, 454A12, directed against transferrin receptors conjugated to a toxin, recombinant ricin A chain. Exposure of proliferating human retinal pigme ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · June 15, 1990
We prospectively studied 194 patients undergoing vitrectomy between July 1988 and April 1989 to determine the incidence of postvitrectomy intraocular fibrin formation and the association of a variety of preoperative and intraoperative variables with the fo ...
Full textLink to itemCite
Journal articleArch Ophthalmol · March 1990
Combined phacoemulsification and pars plana vitrectomy were performed in eight eyes with cataract and vitreoretinal disease. Six eyes had tractional retinal detachment and/or nonclearing vitreous hemorrhage, one eye had a retained metallic intraocular fore ...
Full textLink to itemCite
Journal articleOphthalmology · February 1990
Featured Publication
The authors injected 25 micrograms of recombinant tissue plasminogen activator (tPA) into the anterior chamber or vitreous cavity of 23 eyes of 22 patients with severe intraocular fibrin formation that developed after vitrectomy surgery for complicated cas ...
Full textLink to itemCite
Journal articleBr J Ophthalmol · January 1990
Adequate treatment of juxtapapillary melanomas with episcleral plaque brachytherapy using lower energy radiation sources may be difficult because of uncertainties regarding the relationship of the plaque to the optic nerve and tumour base. We obtained magn ...
Full textLink to itemCite
Journal articleArch Ophthalmol · October 1989
Hyperthermia has been combined with conventional radiation methods to achieve enhanced tumor destruction. We combined iodine 125 seeds with ferromagnetic thermoseeds in a single plaque to simultaneously deliver radiation and heat in a rabbit model of choro ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · August 15, 1989
We injected 25 micrograms of recombinant tissue plasminogen activator into the anterior chamber or the vitreous cavity in seven aphakic patients for pupillary block caused by a complete fibrin pupillary membrane that formed after vitrectomy with fluid-gas ...
Full textLink to itemCite
Journal articleArch Ophthalmol · August 1989
A high-powered argon blue-green laser coupled to a 300-microns quartz fiberoptic probe was used to create an ab interno sclerostomy in a patient undergoing enucleation for a blind painful eye. Despite the presence of diffuse rubeosis, 360 degrees periphera ...
Full textLink to itemCite
Journal articleArch Ophthalmol · January 1989
We studied the use of a 15-W argon blue-green laser in the treatment of choroidal melanoma in a rabbit model. Greene melanoma cells were used to produce 2- to 4-mm thick tumors posteriorly in the suprachoroidal space in pigmented rabbits. Endophotocoagulat ...
Full textLink to itemCite
Journal articleExp Eye Res · January 1989
The expression of Na+-K+ ATPase pumps was studied in cultured human retinal pigment epithelium (RPE). Pump site number was measured by quantitation of the specific binding of [3H]ouabain to cultures of varying density. Specific binding of [3H]ouabain was t ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · October 15, 1988
We used a high-energy argon blue-green laser (15-W maximum power output) to create full-thickness sclerostomies from the region of the anterior chamber angle to the subconjunctival space in pigmented rabbits using an ab interno approach. One to four laser ...
Full textLink to itemCite
Journal articleArch Ophthalmol · August 1988
Twenty-five micrograms of human recombinant tissue plasminogen activator (tPA) was injected intracamerally into the eyes of three aphakic patients who developed severe intraocular fibrin formation within 24 hours after vitrectomy surgery. Fluid obtained fr ...
Full textLink to itemCite
Journal articleOphthalmology · August 1988
The effect of the inspired oxygen concentration (FIO2) on the production of retinal phototoxicity by the operating microscope was studied in phakic rhesus monkeys. One eye of each monkey was exposed to light under conditions of 99% FIO2, and the other eye ...
Full textLink to itemCite
Journal articleArch Ophthalmol · July 1988
We studied the clinical and histopathologic characteristics of the eyes obtained after death from a patient with adult-onset foveomacular pigment epithelial dystrophy. The pigmentation seen in the central fovea corresponded histologically to a hyperplastic ...
Full textLink to itemCite
Journal articleArch Ophthalmol · July 1988
The clearance of tissue plasminogen activator (t-PA) injected into the midvitreous cavity was studied in the phakic, vitrectomized rabbit eye with and without intravitreal fibrin clots. The quantity and activity of t-PA in the vitreous, serum, and aqueous ...
Full textLink to itemCite
Journal articleArch Ophthalmol · June 1988
Eight patients experienced progression of nonproliferative diabetic retinopathy following cataract extraction. Six patients underwent an uncomplicated extracapsular cataract extraction with placement of a posterior chamber intraocular lens, and in two pati ...
Full textLink to itemCite
Journal articleAm J Ophthalmol · March 15, 1987
We performed a prospective, controlled, masked study designed to evaluate the ocular manifestations of preeclampsia in 56 patients, including 25 control, 17 mild preeclamptic, and 14 severe preeclamptic patients. There was a statistically significant corre ...
Link to itemCite
Journal articleOphthalmic Surg · December 1986
We present a case of endophthalmitis caused by Propionibacterium acnes seven months following extracapsular cataract extraction and intraocular lens implantation. The markedly delayed clinical course of endophthalmitis associated with this organism appears ...
Link to itemCite
Journal articleArch Ophthalmol · July 1986
We prospectively studied the age-related changes of the visual fields obtained from a selected group of 25 normal patients. The OCTOPUS automated perimeter was used to test both eyes of each patient using Program 32. We calculated the mean threshold sensit ...
Full textLink to itemCite